Designer Circular RNA as Protein Sponge for Cancer Therapy

Circular RNA, pancreatic cancer therapy, hnRNP L, heterogeneous nuclear ribonucleoprotein L, protein sponging, RNA-binding proteins, molecular medicine, oral squamous cell carcinoma therapy

Designer Circular RNA as Protein Sponge for Cancer Therapy

Kurzbeschreibung:
The new circular RNA enables specific binding and inhibition of heterogeneous nuclear ribonucleoprotein L in cells and thus opens new therapeutic approaches for the treatment of pancreatic and other cancer types, where hnRNP L is deregulated.

PDF-Dokument

Kontakt:
TransMIT GmbH
Kerkrader Str. 3
35394 Gießen
Telefon: +49 (6 41) 9 43 64 - 0
E-Mail: patente@transmit.de

Weiterempfehlen